Federal Trade Commission (FTC) announced that a company that heavily advertised an herbal dietary supplement called "Sagee" to the Chinese-language and Vietnamese-language communities had settled FTC charges of making false and unsubstantiated claims for the product
Before beginning peptide therapy, our providers perform comprehensive laboratory testing to develop a personalized treatment plan based on your individual health profile
BPC-157 is used in non-clinical research involving cellmatrix interaction models, angiogenic pathway studies, and investigations into structural protein activity within controlled experimental systems
The FDAs position is unambiguous: BPC-157 "lacks sufficient safety data and has not been shown to be safe or effective in humans." Key implications: Compounding pharmacies cannot legally compound medications containing BPC-157 under Section 503A or 503B Marketing with therapeutic claims violates federal law regardless of disclaimers Warning letters have been issued to companies marketing BPC-157 as a therapeutic agent WADA Prohibition The World Anti-Doping Agency classifies BPC-157 as a prohibited substance under class S0: Non-Approved Substances , effective January 2023
First discovered in human plasma, GHK-Cu has since been widely researched for its ability to promote skin healing, boost collagen production, and enhance overall tissue repair
